勃起不全治療薬の世界市場レポート 2025年

勃起不全治療薬市場規模は、今後数年間でわずかな成長が見込まれます。2029年にはCAGR1.6％で44億4,000万米ドルに成長します。予測期間の成長は、メンタルヘルス統合への注力、消費者の嗜好の変化、新興国での市場拡大、再生医療の探求、バイオ医薬品の革新に起因すると考えられます。予測期間の主な動向には、新規治療法の開発、意識と教育の向上、ライフスタイルの変化と健康意識、遠隔医療とオンライン相談、革新的な送達システムなどがあります。

慢性疾患の大幅な増加は、勃起不全治療薬市場の主要な促進要因です。勃起不全は主に、心血管疾患、糖尿病、肥満、高血圧など、座りっぱなしのライフスタイルに起因する慢性疾患と関連しています。2023年9月に世界保健機関（WHO）が報告したように、慢性疾患は毎年4,100万人の死亡の原因となっており、世界の全死亡の74％を占めています。慢性疾患の蔓延は、男性の勃起不全の可能性を高め、結果として勃起不全治療薬市場を推進しています。

高血圧の有病率の増加は、当面の勃起不全治療薬市場の成長を促進すると予想されます。高血圧は、動脈壁に対する持続的な高血圧を特徴とし、蔓延している病状です。シルデナフィルのような勃起不全治療薬は、血管機能を改善し、血圧を下げ、血流を促進することで心臓血管全体の健康を促進することで、高血圧の管理に貢献しています。例えば、世界保健機関（WHO）は2023年3月、全世界の30～79歳の成人の推定12億8000万人が高血圧症であり、その3分の2は低・中所得国に居住していると報告しました。したがって、高血圧の有病率の上昇は、勃起不全治療薬市場の成長を促進する要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界勃起不全治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の勃起不全治療薬市場：成長率分析
• 世界の勃起不全治療薬市場の実績：規模と成長, 2019-2024
• 世界の勃起不全治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界勃起不全治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の勃起不全治療薬市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• シルデナフィルクエン酸塩
• ミロデナフィル
• バルデナフィル
• 世界の勃起不全治療薬市場投与方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 話題
• 注射
• 世界の勃起不全治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の勃起不全治療薬市場、シルデナフィルクエン酸塩のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブランド名（バイアグラ）
• 汎用フォーム
• 剤形（錠剤、チュアブル剤）
• 世界の勃起不全治療薬市場ミロデナフィルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブランド名（Mvix）
• 剤形
• 組み合わせ製品
• 世界の勃起不全治療薬市場、バルデナフィルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブランド名（レビトラ、スタキシン）
• 剤形
• 投与経路（経口、溶解性）

第7章 地域別・国別分析

• 世界の勃起不全治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の勃起不全治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 勃起不全治療薬市場：競合情勢
• 勃起不全治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Futura Medical plc
• Zydus Cadila
• Lupin Limited
• Cipla Limited
• Dong-A Pharmaceutical Co.
• Ltd.
• Aurobindo Pharma Ltd.
• Alembic Pharmaceuticals Ltd.
• Lupin Limited
• Glenmark Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• AvKARE Inc.
• Endo Pharmaceuticals Inc.
• Teva Pharmaceutical USA
• Aurobindo Pharma USA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 勃起不全治療薬市場2029：新たな機会を提供する国
• 勃起不全治療薬市場2029：新たな機会を提供するセグメント
• 勃起不全治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Erectile dysfunction (ED) drugs are medications utilized to enhance the effects of nitric oxide, a naturally occurring substance in the body that relaxes penile muscles, aiming to address erectile dysfunction, which is the inability to achieve or maintain a penile erection in men.

Various types of ED drugs include sildenafil citrate, mirodenafil, and vardenafil. Sildenafil, available under trade names such as Viagra, is used to treat erectile dysfunction and pulmonary arterial hypertension. Its effectiveness in treating female genital dysfunction remains uncertain. These drugs can be administered orally, topically, or via injections, and are commonly distributed through hospital pharmacies, retail pharmacies, and online platforms.

The drugs for erectile dysfunction market research report is one of a series of new reports from The Business Research Company that provides drugs for erectile dysfunction market statistics, including drugs for erectile dysfunction industry global market size, regional shares, competitors with drugs for erectile dysfunction market share, detailed drugs for erectile dysfunction market segments, market trends and opportunities, and any further data you may need to thrive in the drugs for erectile dysfunction industry. This drugs for erectile dysfunction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs for erectile dysfunction market size has grown marginally in recent years. It will grow from $4.13 billion in 2024 to $4.16 billion in 2025 at a compound annual growth rate (CAGR) of 0.8%. The growth in the historic period can be attributed to introduction of pde5 inhibitors, pharmaceutical marketing and advertising, changing societal attitudes, rise in lifestyle-induced ed cases, generic medication availability.

The drugs for erectile dysfunction market size is expected to see marginal growth in the next few years. It will grow to $4.44 billion in 2029 at a compound annual growth rate (CAGR) of 1.6%. The growth in the forecast period can be attributed to focus on mental health integration, shift in consumer preferences, market expansion in emerging economies, regenerative medicine exploration, biopharmaceutical innovations. Major trends in the forecast period include development of novel therapies, increasing awareness and education, lifestyle changes and health awareness, telemedicine and online consultations, innovative delivery systems.

The significant rise in the number of chronic diseases is a key driver for the erectile dysfunction drug market. Erectile dysfunction is primarily linked to chronic conditions resulting from a sedentary lifestyle, such as cardiovascular diseases, diabetes, obesity, and high blood pressure. As reported by the World Health Organization (WHO) in September 2023, chronic diseases are responsible for 41 million deaths annually, accounting for 74% of all global deaths. The prevalence of chronic diseases heightens the likelihood of erectile dysfunction among men, consequently propelling the market for erectile dysfunction drugs.

The increasing prevalence of hypertension is anticipated to fuel the growth of the drugs for erectile dysfunction market in the foreseeable future. Hypertension, characterized by sustained high blood pressure against the artery walls, is a prevalent medical condition. Erectile dysfunction drugs, such as sildenafil, contribute to managing hypertension by improving blood vessel function, lowering blood pressure, and promoting overall cardiovascular health through enhanced blood flow. For instance, the World Health Organization (WHO) reported in March 2023 that an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension, with two-thirds residing in low- and middle-income countries. Hence, the escalating prevalence of hypertension is a driving factor in the growth of the drugs for erectile dysfunction market.

Several companies in the erectile dysfunction drugs market are implementing new drug delivery techniques, such as pellets and creams. These innovations offer increased efficacy, performance, and safety in treating erectile dysfunction. For example, in September 2022, Lupin, an India-based pharmaceutical company, launched Sildenafil for oral suspension, 10 mg/mL, approved by the United States Food and Drug Administration (FDA). This drug delivery method provides unique dosages for treating erectile dysfunction, enhancing treatment options and potentially addressing concerns related to side effects.

Major players in the drugs for erectile dysfunction market are strategically focusing on introducing combination capsules, such as therapy capsules, to optimize revenue. Tamsulosin and Tadalafil, a combination of medications targeting benign prostatic hyperplasia (BPH) and erectile dysfunction, is gaining prominence. In September 2023, Akums Drugs & Pharmaceuticals Ltd., an India-based pharmaceutical company, launched a therapy capsule addressing both conditions in the Indian market. This capsule, containing a combination of Tamsulosin and Tadalafil, demonstrates significant improvements in BPH and the Erectile Dysfunction Index. The introduction of such therapy capsules provides a novel treatment option for patients grappling with both conditions, catering to a broader spectrum of needs in the market.

Major companies operating in the drugs for erectile dysfunction market include Pfizer Inc., Eli Lilly and Company, Bayer AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Futura Medical plc, Zydus Cadila, Lupin Limited, Cipla Limited, Dong-A Pharmaceutical Co., Ltd., Aurobindo Pharma Ltd., Alembic Pharmaceuticals Ltd., Lupin Limited, Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., AvKARE Inc., Endo Pharmaceuticals Inc., Teva Pharmaceutical USA, Aurobindo Pharma USA, Hims & Hers Health Inc., Antares Pharma Inc., Acrux Limited, Mankind Pharma Ltd., Futura Medical plc, Adamis Pharmaceuticals Corporation

North America was the largest region in the drugs for erectile dysfunction market in 2024. Middle East is expected to be the fastest-growing region in the global drugs for erectile dysfunction market during the forecast period. The regions covered in the drugs for erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs for erectile dysfunction market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The erectile dysfunction (ED) drugs market consists of sales Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs For Erectile Dysfunction Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs for erectile dysfunction market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs for erectile dysfunction ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs for erectile dysfunction market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drugs: Sildenafil Citrate; Mirodenafil; Vardenafil
• 2) By Mode Of Administration: Oral; Topical; Injections
• 3) By End Users: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Sildenafil Citrate: Brand Names (Viagra); Generic Forms; Dosage Forms (Tablets, Chewables)
• 2) By Mirodenafil: Brand Names (Mvix); Dosage Forms; Combination Products
• 3) By Vardenafil: Brand Names (Levitra, Staxyn); Dosage Forms; Administration Routes (Oral, Dissolvable)
• Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Bayer AG; Viatris Inc.; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs For Erectile Dysfunction Market Characteristics

3. Drugs For Erectile Dysfunction Market Trends And Strategies

4. Drugs For Erectile Dysfunction Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drugs For Erectile Dysfunction Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drugs For Erectile Dysfunction PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drugs For Erectile Dysfunction Market Growth Rate Analysis
• 5.4. Global Drugs For Erectile Dysfunction Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drugs For Erectile Dysfunction Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drugs For Erectile Dysfunction Total Addressable Market (TAM)

6. Drugs For Erectile Dysfunction Market Segmentation

• 6.1. Global Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sildenafil Citrate
• Mirodenafil
• Vardenafil
• 6.2. Global Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Injections
• 6.3. Global Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Drugs For Erectile Dysfunction Market, Sub-Segmentation Of Sildenafil Citrate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brand Names (Viagra)
• Generic Forms
• Dosage Forms (Tablets, Chewables)
• 6.5. Global Drugs For Erectile Dysfunction Market, Sub-Segmentation Of Mirodenafil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brand Names (Mvix)
• Dosage Forms
• Combination Products
• 6.6. Global Drugs For Erectile Dysfunction Market, Sub-Segmentation Of Vardenafil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brand Names (Levitra, Staxyn)
• Dosage Forms
• Administration Routes (Oral, Dissolvable)

7. Drugs For Erectile Dysfunction Market Regional And Country Analysis

• 7.1. Global Drugs For Erectile Dysfunction Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drugs For Erectile Dysfunction Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drugs For Erectile Dysfunction Market

• 8.1. Asia-Pacific Drugs For Erectile Dysfunction Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drugs For Erectile Dysfunction Market

• 9.1. China Drugs For Erectile Dysfunction Market Overview
• 9.2. China Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drugs For Erectile Dysfunction Market

• 10.1. India Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drugs For Erectile Dysfunction Market

• 11.1. Japan Drugs For Erectile Dysfunction Market Overview
• 11.2. Japan Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drugs For Erectile Dysfunction Market

• 12.1. Australia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drugs For Erectile Dysfunction Market

• 13.1. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drugs For Erectile Dysfunction Market

• 14.1. South Korea Drugs For Erectile Dysfunction Market Overview
• 14.2. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drugs For Erectile Dysfunction Market

• 15.1. Western Europe Drugs For Erectile Dysfunction Market Overview
• 15.2. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drugs For Erectile Dysfunction Market

• 16.1. UK Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drugs For Erectile Dysfunction Market

• 17.1. Germany Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drugs For Erectile Dysfunction Market

• 18.1. France Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drugs For Erectile Dysfunction Market

• 19.1. Italy Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drugs For Erectile Dysfunction Market

• 20.1. Spain Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drugs For Erectile Dysfunction Market

• 21.1. Eastern Europe Drugs For Erectile Dysfunction Market Overview
• 21.2. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drugs For Erectile Dysfunction Market

• 22.1. Russia Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drugs For Erectile Dysfunction Market

• 23.1. North America Drugs For Erectile Dysfunction Market Overview
• 23.2. North America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drugs For Erectile Dysfunction Market

• 24.1. USA Drugs For Erectile Dysfunction Market Overview
• 24.2. USA Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drugs For Erectile Dysfunction Market

• 25.1. Canada Drugs For Erectile Dysfunction Market Overview
• 25.2. Canada Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drugs For Erectile Dysfunction Market

• 26.1. South America Drugs For Erectile Dysfunction Market Overview
• 26.2. South America Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drugs For Erectile Dysfunction Market

• 27.1. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drugs For Erectile Dysfunction Market

• 28.1. Middle East Drugs For Erectile Dysfunction Market Overview
• 28.2. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drugs For Erectile Dysfunction Market

• 29.1. Africa Drugs For Erectile Dysfunction Market Overview
• 29.2. Africa Drugs For Erectile Dysfunction Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drugs For Erectile Dysfunction Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drugs For Erectile Dysfunction Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drugs For Erectile Dysfunction Market Competitive Landscape And Company Profiles

• 30.1. Drugs For Erectile Dysfunction Market Competitive Landscape
• 30.2. Drugs For Erectile Dysfunction Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Drugs For Erectile Dysfunction Market Other Major And Innovative Companies

• 31.1. Futura Medical plc
• 31.2. Zydus Cadila
• 31.3. Lupin Limited
• 31.4. Cipla Limited
• 31.5. Dong-A Pharmaceutical Co.
• 31.6. Ltd.
• 31.7. Aurobindo Pharma Ltd.
• 31.8. Alembic Pharmaceuticals Ltd.
• 31.9. Lupin Limited
• 31.10. Glenmark Pharmaceuticals Ltd.
• 31.11. Sun Pharmaceutical Industries Ltd.
• 31.12. AvKARE Inc.
• 31.13. Endo Pharmaceuticals Inc.
• 31.14. Teva Pharmaceutical USA
• 31.15. Aurobindo Pharma USA

32. Global Drugs For Erectile Dysfunction Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drugs For Erectile Dysfunction Market

34. Recent Developments In The Drugs For Erectile Dysfunction Market

35. Drugs For Erectile Dysfunction Market High Potential Countries, Segments and Strategies

• 35.1 Drugs For Erectile Dysfunction Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drugs For Erectile Dysfunction Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drugs For Erectile Dysfunction Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer